Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced its wholly-owned…
Author: admin
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
BriSTAR Immunotech, a clinical-stage cell therapy company, announced today it will showcase its T-cell receptors (TCR)…
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties
On January 16, the second stage of “A Healthy Winter Action” initiated by Fosun Foundation in conjunction…
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S.…
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression
Duality Biologics (“DualityBio”), a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug…
Castor Oil-Based Biopolymer Global Market Report 2022: Sector to Reach $3.32 Billion by 2031 at a 16.7% CAGR
The “Castor Oil-Based Biopolymer Market – A Global and Regional Analysis: Focus on End User, Polymer Type,…
FDA approves Orthogen’s IDE
Orthogen AG, a leader in molecular medicine, announces U.S. Food and Drug Administration (FDA) approval of…
US MEDICAL GLOVE (USMG) RECEIVES WORLD’S FIRST FDA 510(k) CLEARANCE FOR CHEMO-RATED PATIENT EXAM GLOVES PRODUCED USING ITS OWN MANUFACTURED AMERICAN-MADE MACHINES
USMG is now in 24-hour production, selling and shipping daily cartons of both its patient examination…
Patient lateral transfer market size to increase by USD 335.69 million; North America to contribute 37% of market growth – Technavio
The Patient Lateral Transfer Market by Product, Usage, and Geography – Forecast and Analysis 2023-2027 report has been…
Healthcare private equity market shows resilience with second strongest year on record, despite economic and geopolitical disruptions–preview of Bain & Company analysis
Despite a tail of two halves, a near-record-setting pace of healthcare private equity dealmaking, in terms…